Common Contracts
4 similar Agreement contracts by Idexx Laboratories Inc /De
AGREEMENTAgreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
THIS AGREEMENT is made effective as of the 16th day of October, 2003, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
AGREEMENTAgreement • February 16th, 2022 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
THIS AGREEMENT is made effective as of the 17th day of October, 2003, between IDEXX Europe B.V., a corporation organized under the law of The Netherlands whose principal place of business is at Koolhovenlaan 20, 1119 NE - Schiphol-Rijk, The Netherlands (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”), and amends and restates the supply agreement effective as of January 1, 1999 between IDEXX and OCD (the “Prior Europe Agreement”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AGREEMENTAgreement • March 3rd, 2004 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
THIS AGREEMENT is made effective as of the 17th day of October, 2003, between IDEXX Europe B.V., a corporation organized under the law of The Netherlands whose principal place of business is at Koolhovenlaan 20, 1119 NE - Schiphol-Rijk, The Netherlands (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”), and amends and restates the supply agreement effective as of January 1, 1999 between IDEXX and OCD (the “Prior Europe Agreement”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AGREEMENTAgreement • March 3rd, 2004 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances • New York
THIS AGREEMENT is made effective as of the 16th day of October, 2003, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
